pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Beam Therapeutics Inc. ($BEAM) · news · pharmadog
← back to Beam Therapeutics Inc.
News mentioning $BEAM
46
stories
11h
STAT+: Pharmalittle: We’re reading about a Vaxcyte pneumococcal shot, increasing pharma M&A, and more
stat
17h
Trio of scientists who developed neuron light switches win Nobel Prize in Physiology or Medicine
fiercebiotech
3d
STAT+: Up and down the ladder: The latest comings and goings
stat
3d
STAT+: Pharmalittle: We’re reading about the 340B drug pilot program, an obesity drug disappointment, and more
stat
4d
Mistrust in science and a juicy gene-editing lawsuit
stat
4d
STAT+: Pharmalittle: We’re reading about a plan to lower Medicare drug prices, a Lilly obesity drug, and more
stat
4d
STAT+: In Shanghai’s ‘Science City,’ China’s ascendant biotechs make their pitch to the world
stat
5d
STAT+: HHS announces new efforts to speed up, expand clinical trials with AI
stat
5d
STAT+: Eli Lilly’s Zepbound combined with amylin drug led to significant weight loss in mid-stage trial
stat
5d
STAT+: Three biotech updates, including accusations of theft and and a new lobbying leader
stat
5d
STAT+: Pharmalittle: We’re reading about Beam suing over IP theft, a Trump rule on importing meds, and more
stat
5d
Beam Therapeutics sues base editing rival, claims former scientist stole secrets
fiercebiotech
5d
Opinion: America’s biotech race with China must be won at home
stat
6d
Beam sues YolTech and Serapha Bio for allegedly stealing its gene editing tech
endpoints
6d
Beam sues 2 biotechs, alleging theft of base editing trade secrets
biopharma dive
6d
STAT+: Beam Therapeutics sues Chinese biotech, VC-backed startup, alleging theft of intellectual property
stat
27d
#ERS26: Beam says AATD base editing data hold up after one year
endpoints
Sep 3, 26
Chutes & Ladders—Invivyd's chairman adds CEO role ahead of COVID readout
fiercebiotech
Aug 31, 26
A winner, a loser, and a mid-stage signal from a major cardiology research conference
stat
Aug 21, 26
Focal therapy for localized prostate cancer has divided physicians. Will new data change minds?
stat
Aug 10, 26
STAT+: The promise of radiopharmaceuticals smacks into safety concerns
stat
Aug 5, 26
Bespoke gene-editing outfit abandons lead program, cuts ‘several’ employees
biospace
Aug 5, 26
4 potential biotech M&A targets, plus a pretty sure bet from J&J
biospace
Aug 4, 26
STAT+: Startup promising to scale custom CRISPR therapies abruptly scraps plans
stat
Jul 28, 26
STAT+: From ‘lost cause’ to gold rush: Biotechs swarm to cure AATD
stat
Jul 13, 26
STAT+: UnitedHealth’s questionable review, and more MA stars lawsuits
stat
Jul 13, 26
STAT+: All eyes on data on Biogen’s tau therapy
stat
Jul 13, 26
STAT+: A breakthrough in pancreatic cancer has experts excited — and braced for what’s to come
stat
Jul 12, 26
STAT+: Tau in the spotlight at Alzheimer’s conference
stat
Jul 10, 26
STAT+: Roche ends Huntington’s gene-silencing programs
stat
← prev
page 1 of 2
next →
